Management of adult T-cell leukaemia/lymphoma

British Journal of Haematology

Volumn 100, Issue 3, 1998, Pages 453-458

  Pawson, Rachel ^b   Mufti, Ghulam J ^a   Pagliuca, Antonio ^a  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b ROYAL FREE HOSPITAL   (United Kingdom)

Author keywords

ATLL; CNS prophylaxis; HTLV I; Intensive chemotherapy

Indexed keywords

ACEPROMAZINE; CARMUSTINE; CYCLOPHOSPHAMIDE; CYTARABINE; DNA TOPOISOMERASE INHIBITOR; DOXORUBICIN; ETOPOSIDE; LAMIVUDINE; PREDNISOLONE; VINCRISTINE; ZIDOVUDINE;

BONE MARROW BIOPSY; BONE MARROW TRANSPLANTATION; DNA REPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN CELL; HUMAN T CELL LEUKEMIA VIRUS; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; REVIEW; T CELL LEUKEMIA; T CELL LYMPHOMA;

ADULT; ANTINEOPLASTIC AGENTS; BONE MARROW TRANSPLANTATION; HUMANS; LEUKEMIA-LYMPHOMA, T-CELL, ACUTE, HTLV-I-ASSOCIATED; PROGNOSIS;

EID: 15644362967     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.00582.x     Document Type: Review

References (61)

1. Bazarbachi, A. & Hermine, O. (1996) Treatment with a combination of zidovudine and α-interferon in naive and pretreated adult T-cell leukemia/lymphoma patients. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 13, (Suppl. 1), S186-S190.
2. Borg, A., Liu Yin, J.A., Johnson, P.R.E., Tosswill, J., Saunders, M. & Morris, D. (1996) Successful treatment of HTLV-I-associated acute adult T-cell leukaemia lymphoma by allogeneic bone marrow transplantation. British Journal of Haematology, 94, 713-715.
3. Brennan, M., Runganga, J., Barbara, J.A.J., Contreras, M., Tedder, R.S., Garson, J.A., Tuke, P.W., Mortimer, P.P., McAlpine, L. & Tosswill, J.H.C. (1993) Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. British Medical Journal, 307, 1235-1239.
4. Brito-Babapulle, F., Arya, R., Griffiths, T., Pagliuca, A. & Mufti, G.J. (1992) BEAM regimen and G-CSF in HTLV-I-associated T-cell lymphoma. Lancet, 339, 133-134.
5. Chen, Y-C., Wang, C-H., Su, I-J., Hu, C-Y., Chou, M-J., Tun-Ho, L., Dong-Tsamn, L., Chung, T-Y., Liu, C-H. & Yang, C-S. (1989) Infection of HTLV type I and development of human T-cell leukemia/lymphoma in patients with hematologic neoplasms: a possible linkage to blood transfusion. Blood, 74, 388-394.
6. Coste, J., Lemaire, J.M., Barin, F. & Courouce, A.M. (1990) HTLV-I/II antibodies in French blood donors. Lancet, 335, 1167-1168.
7. Courouce, A.M., Pillonel, J., Lemaire, J.M., Maniez, M. & Brunet, J.B. (1993) Seroepidemiology of HTLV-I/II in universal screening of blood donations in France. Journal of Acquired Immune Deficiency Syndrome, 7, 841-847.
8. Cunningham, D., Gilchrist, N.G., Jack, A., Dalgleish, A.G., Soukop, M. & Lee, F.D. (1985) T-lymphoma associated with HTLV-I outside the Caribbean and Japan. Lancet, ii, 337-338.
9. Dalgleish, A.G. (1993) Human T-cell leukaemia/lymphoma virus and blood donation. British Medical Journal, 307, 1224-1225.
10. de The, G. & Kazanji, M. (1996) An HTLV-I/II vaccine: from animal models to clinical trials? Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 13, (Suppl. 1), S191-198.
11. Ezaki, K., Hirano, M., Ohno, R., Yamada, K., Naito, K., Hirota, Y., Shirakawa, S. & Kimura, K. (1991) A combination trial of human lymphoblastoid interferon and bestrabucil (KM2210) for adult T-cell leukemia/lymphoma. Cancer, 68, 695-698.
12. Giesecke, J. (1995) HTLV screening of Swedish blood donors. Lancet, 345, 978.
13. Gill, P.S., Harrington, W., Kaplan, M.H., Ribiero, R.C., Bennett, J.M., Liebman, H.A., Bernstein-Singer, M., Espina, B.M., Cabral, L., Allen, S., Kornblau, S., Pike, M.C. & Levine, A.M. (1995) Treatment of adult T-cell leukemia-lymphoma with a combination of interferon alfa and zidovudine. New England Journal of Medicine, 332, 1744-1748.
14. Greene, W.C., Leonard, W.J., Depper, J.M., Nelson, D.L. & Waldman, T.A. (1986) The human interleukin-2 receptor: normal and abnormal expression in T-cells and in leukemias induced by the human T-lymphotropic retroviruses. Annals of Internal Medicine, 105, 560-572.
15. Gurtsevitch, V., Senjuta, N., Pavlish, O., Shih, J., Pivnik, A., Yakhina, E., Stepina, V., Kremenetskaya, I. & Syrtsev, A. (1993) Clinical, morphological and virological features of an HTLV-I positive case of adult T-cell leukemia in a white man from the Caucasus. Leukemia Research, 17, 621-627.
16. Hanchard, B. (1996) Adult T-cell leukemia/lymphoma in Jamaica: 1986-1995. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 13, (Suppl. 1), S20-S25.
17. Hermine, O., Bouscary, D., Gessain, A., Turlure, P., Leblond, Franck, N., Buzyn-Veil, A., Rio, B., Macintyre, E., Dreyfus, F. & Bazarbachi, A. (1995) Treatment of adult T-cell leukemia-lymphoma with zidovudine and interferon alfa. New England Journal of Medicine, 332, 1749-1751.
18. Ichihashi, T., Kiyoi, H., Fukutani, H., Kubo, K., Yamauchi, T., Noae, T., Yamada, K. & Ohno, R. (1992) Effective treatment of adult T cell leukemia/lymphoma with a novel oral antitumour agent, MST-16. Oncology, 49, 333-335.
19. Kaplan, J.E., Khabbaz, R.F., Murphy, E.L., Hermansen, S., Roberts, C., Lal, R., Heneine, W., Wright, D., Matijas, L., Thomson, R., Rudolph, D., Switzer, W.M., Kleinman, S., Busch, M. & Schreiber, G.B., and the Retrovirus Epidemiology Donor Study Group (1996) Male-to-female transmission of human T-cell lymphotropic virus types I and II: association with viral load. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 12, 193-201.
20. Kawano, F., Yamaguchi, K., Nishimura, H., Tsuda, H. & Takatsuki, K. (1985) Variation in clinical courses of adult T-cell leukemia. Cancer, 55, 851-856.
21. Komuro, A., Hayami, M., Fujii, H., Miyahara, S. & Hirayama, M. (1983) Vertical transmission of adult T-cell leukemia virus. Lancet, i, 240.
22. Kuwazuru, Y., Hanada, S., Furukawa, T., Yoshimura, A., Sumizawa, T., Utsonomiya, A., Ishibashi, K., Saito, T., Uozimi, K., Maruyama, M., Ishizawa, M., Arima, T. & Akiyama, S. (1990) Expression of P-glycoprotein in adult T-cell leukemia cells. Blood, 76, 2065-2071.
23. Lee, H.H., Swanson, P., Shorty, V.S., Zack, J.A., Rosenblatt, J.D. & Chen, I.S.Y. (1989) High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science, 244, 471-475.
24. Ljungman, P., Lawler, M., Asjo, B., Bogdanovic, G., Karlsson, K., Malam, C., McCann, S.R., Ringden, O. & Gahrton, G. (1994) Infection of donor lymphocytes with HTLV-I following allogeneic bone marrow transplantation for HTLV-I positive ATL. British Journal of Haematology, 88, 403-405.
25. Lofters, W., Campbell, M. Gibbs, N. & Cheson, B.D. (1987) 2′-deoxycoformycin therapy in adult T-cell leukemia/lymphoma. Cancer, 60, 2605-2608.
26. Lymphoma Study Group (1984-87) (1991) Major prognostic factors of patients with adult T-cell leukemia-lymphoma: a cooperative study. Leukemia Research, 15, 81-90.
27. Manzari, V., Gardilone, A., Barillari, G., Zani, M., Collalti, E., Pandolti, F., de Rossi, G., Liso, V., Babbo, P., Robert-Guroff, M. & Frati, L. (1985) HTLV-I is endemic in Southern Italy: detection of the first infectious cluster in a white population. International Journal of Cancer, 36, 557-559.
28. Matutes, E. & Catovsky, D. (1991) Mature T-cell leukemias and leukemia/lymphoma syndromes. Leukemia and Lymphoma, 4, 81-91.
29. Miyoshi, I., Murata, N., Machida, H. & Taguchi, H. (1995) Transmission of human T-lymphotropic virus type I by bone marrow transplantation. British Journal of Haematology, 89, 690-691.
30. Murphy, E.L., Hanchard, B., Figueroa, J.P., Gibbs, W.N., Campbell, M., Goedert, J.J. & Blattner, W.A. (1989) Modelling the risk of adult T-cell leukemia/lymphoma in persons affected with human T-lymphotropic virus type I. International Journal of Cancer, 43, 250-253.
31. Nagafuji, K., Harada, M., Teshima, T., Eto, T., Takamatsu, Y., Okamura, T., Murakawa, M., Akashi, K. & Niho, Y. (1993) Hematopoietic progenitor cells from patients with adult T-cell leukemia-lymphoma are not infected with human T-cell leukemia virus type I. Blood, 82, 2823-2828.
32. Ohno, R., Masaoka, T., Shirakawa, S., Sakamoto, S., Hirano, M., Hanada, S., Yasunaga, K., Yokomaku, S., Mitomo, Y., Nagai, K., Yamada, K. & Furue, H. (1993) Treatment of adult T-cell leukemia/lymphoma with MST-16, a new oral antitumour drug and a derivative of bis(2,6-dioxopiperazine). Cancer, 71, 2217-2221.
33. Okochi, K., Sato, H. & Hinuma, Y. (1984) A retrospective study on transmission of adult T cell leukaemia virus by blood transfusion: seroconversion in recipients. Vox Sanguinis, 46, 245-253.
34. Osame, M., Izumo, S., Igata, A., Matsumoto, M., Matsumoto, T., Sonada, S., Tara, M. & Shibata, Y. (1986) Blood transfusion and HTLV-I associated myelopathy. Lancet, ii, 104-105.
35. Pagliuca, A., Layton, D.M. & Mufti, G.J. (1988) Hyperinfection with Strongyloides after treatment of adult T-cell leukaemia-lymphoma in an African immigrant. British Medical Journal, 297, 1456-1457.
36. Pagliuca, A., Pawson, R. & Mufti, G.J. (1995) HTLV-I screening in Britain. British Medical Journal, 311, 1313-1314.
37. Pawson, R., Richardson, D.S., Pagliuca, A., Kelsey, S.M., Hoque, S., Breuer, J., Newland, A.C. & Mufti, G.J. (1998) Adult T-cell leukemia/lymphoma in London: clinical experience of 21 cases. Leukemia and Lymphoma, in press.
38. Poiesz, B.J., Ruscetti, F.W., Gazdar, A.F., Bunn, P.A., Minna, J.A. & Gallo, R.C. (1980) Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proceedings of the National Academy of Sciences of the United States of America, 77, 7415-7419.
39. Pombo de Oliviera, M.S., Matutes, E.M., Schulz, T.F., Carvalho, S.M., Noronha, H., Reaves, J.D., Loureiro, P., Machado, C. & Catovsky, D. (1995) T-cell malignancies in Brazil: clinico-pathological and molecular studies of HTLV-I-positive and -negative cases. International Journal of Cancer, 60, 823-827.
40. Robert-Guroff, M., Ruscetti, F.W., Posner, L.E., Poiesz, B.J. & Gallo, R.C. (1984) Detection of the human T-cell lymphoma virus p19 in cells of some patients with cutaneous T-cell lymphoma and leukemia using a monoclonal antibody. Journal of Experimental Medicine, 154, 1957-1964.
41. + HTLV-I-related adult T-cell leukemia/ lymphoma in an Iranian woman. Leukemia and Lymphoma, 12, 471-476.
42. Shimomoto, Y., Miyahara, M., Yamada, H., Shibata, K., Matsuzaki, M. & Ono, K. (1996) ATLL with multiple integrations of HTLV-I proviral DNA: differing clinical features are linked to varied proviral integration. British Journal of Haematology, 92, 632-638.
43. Shimoyama, M. (1992) Treatment of patients with adult T-cell leukemia-lymphoma: an overview. Gann Monographs on Cancer Research, 39, 43-56.
44. Shimoyama, M., and members of the Lymphoma Study Group (1991) Diagnostic criteria and classification of clinical subtypes of adult T-cell leukaemia/lymphoma. British Journal of Haematology, 79, 428-437.
45. Suzumiya, J., Maratsuka, K., Nabeshima, K., Nawa, Y., Koono, M., Tamura, K., Kimura, N., Hisano, S., Tachibana, N., Inoue, S. & Sumiyoshi, A. (1993) Autopsy findings in 47 cases of adult T-cell leukemia/lymphoma in Miyazaki prefecture. Japan. Leukemia and Lymphoma, 11, 281-286.
46. Taguchi, H., Kinoshita, K., Takatsuki, K., Tomonaga, M., Araki, K., Arima, N., Ikeda, S., Uozimi, K., Kohno, H., Kawano, F., Kikucji, H., Takahasi, H., Tamura, K., Chiyoda, S., Tsuda, H., Nishimura, H., Hosokaw, T., Matsuzaki, H., Momita, S., Yamada, O. & Miyoshi, I. (1996) An intensive chemotherapy of adult T-cell leukemia/ lymphoma: CHOP followed by etoposide, vindesine, ranimustine, and mitoxantrone with granulocyte colony-stimulating factor support. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 12, 182-186.
47. Taguchi, H., Kobayashi, M. & Miyoshi, I. (1991) Immunosuppression by HTLV-I infection. Lancet, 337, 308-309.
48. Takatsuki, K., Uchiyama, T., Sagawa, K. & Yodoi, J. (1977) Adult T cell leukemia in Japan. Topics in Hematology (ed. by S. Seno, F. Takaku and S. Irino), pp. 73-77. Excerpta Medica, Amsterdam.
49. Tamura, K., Makino, S. Araki, Y., Imamura, T. & Seita, M. (1987) Recombinant interferon beta and gamma in the treatment of adult T-cell leukaemia. Cancer, 59, 1059-1062.
50. Tsuda, H., Takatsuki, K., Ohno, K., Masaoka, T., Okada, K., Shirakawa, S., Oyashi, Y. & Ota, K. (1994) Treatment of adult T-cell leukaemia/lymphoma with irinotecan hydrochloride (CPT-11). British Journal of Cancer, 70, 771-774.
51. Tsukasaki, K., Ikeda, S., Murata, K., Maeda, T., Atogami, S., Sohda, H., Momita, S., Jubashi, T., Yamada, Y., Mine, M., Kamihira, S. & Tomonaga, M. (1995) Characteristics of chemotherapy-induced clinical remission in long survivors with aggressive adult T-cell leukemia/lymphoma. Leukemia Research, 17, 157-166.
52. Tsukasaki, K., Tsushima, H., Yamamura, H., Hata, T., Murata, K., Maeda, T., Atogami, S., Sohda, H., Momita, S., Ideda, S., Katamine, S., Yamada, Y. & Kamihira, S. (1997) Integration patterns of HTLV-I provirus in relation to the clinical course of ATL: frequent clonal change at crisis from indolent disease. Blood, 89, 948-956.
53. Uchiyama, T., Yodoi, J., Sagawa, K., Takatsuki, K. & Uchino, H. (1997) Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood, 50, 481-492.
54. Uozimi, K., Hanada, S., Ohno, N., Ishitsuka, K., Shimotakahara, S., Otsuka, M., Chyuman, Y., Nakahara, K., Takeshita, T., Kuwazuru, Y., Saito, T., Makino, T., Iwahashi, M., Utsunomiya, A. & Arima, T. (1995) Combination chemotherapy (RCM protocol: response-oriented cyclic multidrug protocol) for the acute or lymphoma type adult T-cell leukemia. Leukemia and Lymphoma, 18, 317-323.
55. Veelken, H., Kohler, G., Schneider, J., Dierbach, H., Mertelsman, R., Schaefer, H.E. & Lubbert, M. (1996) HTLV-I-associated adult T cell leukemia/lymphoma in two patients from Bucharest. Romania. Leukemia, 10, 1366-1369.
56. Vrielink, H., van der Poel, C.L. & Reesnik, H.W. (1995) Efficacy of selected versus random blood donor screening for anti-HTLV-I antibodies. Vox Sanguinis, 68, 251-252.
57. Waldman, T.A. (1996) The promiscuous IL-2/IL-15 receptor: a target for immunotherapy of HTLV-1-associated disorders. Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology, 13, (Suppl. 1), S179-S185.
58. Waldmann, T.A., White, J.D., Goldman, C.K., Top, L., Grant, A., Bamford, R., Roessler, E., Horak, I.D., Zaknoen, S., Kasten-Sportes, C., England, R., Horak, E., Mishra, B., Dipre, M., Hale, P., Fleisher, T.A., Junghaus, R.P., Jaffe, E.S. & Nelson, D.L. (1993) The interleukin-2 receptor: a target for monoclonal antibody treatment of human T-cell lymphotropic virus-I-induced adult T-cell leukemia. Blood, 82, 1701-1712.
59. Whittaker, S.J., Ng, Y.L., Rustin, M., Levene, G., McGibbon, D.H. & Smith, N.P. (1993) HTLV-I-associated cutaneous disease: a clinico-pathological and molecular study of patients from the U.K. British Journal of Dermatology, 128, 483-492.
60. Yamaguchi, K. (1994) HTLV-1 in Japan. Lancet, 343, 213-215.
61. Yamaguchi, K., Yul, L.S., Oda, T., Maeda, Y., Ishii, M., Fujita, K., Kagiyama, S., Nagai, K., Suzuki, H. & Takatsuki, K. (1986) Clinical consequences of 2′-deoxycoformycin therapy in patients with refractory adult T-cell leukemia. Leukemia Research, 10, 989-993.